The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

Several large drugmakers will ask the Trump administration to pause Medicare drug-price negotiations, even as Biden-appointed ...

Designed by industry leader Clearlight®, the PERSONAL Red Light Therapy Tower (“the PERSONAL Tower”) shines bright as the mid-level wellness marvel that supports health, inside and out. The 2024 “Best ...

As 2025 begins, we would like to reflect on last year’s regulatory developments in the biologics and biosimilars space. Here are ...

EYLEA HD® and EYLEA® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on preliminary (unaudited) results EYLEA HD ...

Researchers have found that pharmacy benefit managers (PBMs) -- organizations that negotiate access to medicines for most patients in the United States -- steer patients to use their own pharmacies.

What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Low-level laser therapy is a non-invasive treatment for TMJ symptoms that uses light to stimulate cellular activity, and it's ...

The price at which the PBM obtains the drug for its clients is the net price – the list price minus the drugmaker’s discount. If a drugmaker increases its rebate, the net price falls, even if the ...

As I sat outside a coffee shop earlier this year on a tall barstool, my feet resting on its base, it occurred to me that, once again, I was doing wellness wrong. An “earther” – not to be ...